Impact Biomedical Inc.
IBO- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001834105
In the last 90 days, Impact Biomedical Inc. insiders filed 0 open-market purchases and 1 sale; 23 institutions reported holding it in 13F filings for Q2 2026, worth $1.76M in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in Impact Biomedical Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 17
- +6 vs. Q4 2024
- Shares held
- 385.8K
- +296.8K (+333.2%) vs. Q4 2024
- Total value
- $335.4K
- +$259.2K (+340.5%) vs. Q4 2024
- New holders
- 7
- 5 more added
- Sold out
- 1
- 0 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IBO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 23 | $1.76M |
| Q1 2026 | 21 | $2.23M |
| Q4 2025 | 24 | $726.3K |
| Q3 2025 | 21 | $357.8K |
| Q2 2025 | 20 | $328.2K |
| Q1 2025 | 17 | $335.4K |
| Q4 2024 | 11 | $76.1K |
| Q3 2024 | 10 | $59.3K |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Impact Biomedical Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 126,446 | $110.0K | 0.00% | +126,446 | New |
| HRT Financial LP | 68,158 | $59.0K | 0.00% | +68,158 | New |
| Citadel Advisors LLC | 60,315 | $52.5K | 0.00% | +60,315 | New |
| Ferguson Wellman Capital Management, Inc | 36,364 | $31.6K | 0.00% | 00.0% | Unchanged |
| BlackRock, Inc. | 30,675 | $26.7K | 0.00% | +30,675 | New |
| Geode Capital Management, LLC | 23,200 | $20.2K | 0.00% | +2,426+11.7% | Added |
| UBS Group AG | 16,167 | $14.1K | 0.00% | +11,915+280.2% | Added |
| State Street Corp | 11,797 | $10.3K | 0.00% | +626+5.6% | Added |
| Morgan Stanley | 7,800 | $6.79K | 0.00% | +7,800 | New |
| Tower Research Capital LLC (TRC) | 3,766 | $3.28K | 0.00% | +6+0.2% | Added |
| Wells Fargo & Company | 1,029 | $895 | 0.00% | +1,000+3,448.3% | Added |
| Newbridge Financial Services Group, Inc. | 86 | $75 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 17 | $14 | 0.00% | 00.0% | Unchanged |
| Danske Bank A/S | 3 | $3 | 0.00% | 00.0% | Unchanged |
| Signature Resources Capital Management, LLC | 4 | $3 | 0.00% | +4 | New |
| Group One Trading, L.P. | 1 | $1 | 0.00% | 00.0% | Unchanged |
| CWM, LLC | 1 | $0 | 0.00% | +1 | New |
| FNY Investment Advisers, LLC | 0 | $0 | 0.00% | −12,600−100.0% | Sold out |